KCM Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
14,031
-548
-4% -$44.2K 0.03% 213
2026
Q1
$1.26M Buy
14,579
+488
+3% +$46.8K 0.04% 201
2025
Q4
$1.35M Sell
14,091
-632
-4% -$61.4K 0.04% 194
2025
Q3
$1.4M Sell
14,723
-868
-6% -$79.8K 0.05% 192
2025
Q2
$1.36M Buy
15,591
+3,198
+26% +$271K 0.05% 187
2025
Q1
$1.11M Sell
12,393
-1,926
-13% -$172K 0.04% 194
2024
Q4
$1.14M Sell
14,319
-2,792
-16% -$242K 0.04% 193
2024
Q3
$1.54M Sell
17,111
-5,638
-25% -$474K 0.05% 181
2024
Q2
$1.79M Sell
22,749
-37,212
-62% -$3.05M 0.06% 162
2024
Q1
$5.23M Sell
59,961
-28,496
-32% -$2.43M 0.19% 92
2023
Q4
$7.29M Sell
88,457
-6,416
-7% -$489K 0.29% 77
2023
Q3
$7.43M Sell
94,873
-4,766
-5% -$399K 0.32% 72
2023
Q2
$8.78M Sell
99,639
-2,846
-3% -$245K 0.35% 65
2023
Q1
$8.26M Sell
102,485
-2,141
-2% -$175K 0.33% 68
2022
Q4
$8.13M Buy
104,626
+279
+0.3% +$22.6K 0.35% 73
2022
Q3
$8.43M Buy
104,347
+823
+0.8% +$74K 0.39% 62
2022
Q2
$9.29M Sell
103,524
-385
-0.4% -$39K 0.41% 61
2022
Q1
$11.5M Buy
103,909
+1,571
+2% +$166K 0.42% 63
2021
Q4
$10.6M Buy
102,338
+3,349
+3% +$388K 0.37% 68
2021
Q3
$12.4M Buy
98,989
+3,278
+3% +$424K 0.49% 56
2021
Q2
$11.9M Buy
95,711
+22
+0% +$2.76K 0.48% 56
2021
Q1
$11.3M Buy
95,689
+225
+0.2% +$26.4K 0.5% 56
2020
Q4
$11.2M Sell
95,464
-30
-0% -$3.3K 0.54% 52
2020
Q3
$9.92M Buy
95,494
+3,257
+4% +$327K 0.55% 52
2020
Q2
$8.46M Sell
92,237
-1,172
-1% -$112K 0.48% 57
2020
Q1
$8.42M Sell
93,409
-1,894
-2% -$201K 0.57% 54
2019
Q4
$10.8M Sell
95,303
-1,014
-1% -$111K 0.59% 50
2019
Q3
$10.5M Sell
96,317
-272
-0.3% -$28.4K 0.61% 48
2019
Q2
$9.41M Buy
96,589
+1,270
+1% +$116K 0.56% 52
2019
Q1
$8.68M Buy
95,319
+6,441
+7% +$576K 0.56% 52
2018
Q4
$8.08M Sell
88,878
-1,164
-1% -$109K 0.53% 52
2018
Q3
$8.86M Buy
90,042
+1,525
+2% +$141K 0.51% 50
2018
Q2
$7.58M Buy
88,517
+382
+0.4% +$31.9K 0.47% 53
2018
Q1
$7.07M Buy
88,135
+1,408
+2% +$116K 0.43% 63
2017
Q4
$7M Buy
86,727
+1,622
+2% +$130K 0.41% 66
2017
Q3
$6.62M Buy
85,105
+3,117
+4% +$259K 0.4% 71
2017
Q2
$7.28M Buy
81,988
+2,674
+3% +$225K 0.46% 62
2017
Q1
$6.39M Sell
79,314
-8,208
-9% -$641K 0.41% 69
2016
Q4
$6.23M Buy
87,522
+3,966
+5% +$312K 0.42% 69
2016
Q3
$7.22M Sell
83,556
-1,595
-2% -$139K 0.49% 54
2016
Q2
$7.39M Buy
85,151
+388
+0.5% +$31.4K 0.52% 53
2016
Q1
$6.36M Sell
84,763
-330
-0.4% -$24.9K 0.47% 61
2015
Q4
$6.54M Buy
85,093
+2,875
+3% +$216K 0.52% 52
2015
Q3
$5.5M Buy
82,218
+380
+0.5% +$28K 0.46% 62
2015
Q2
$6.06M Buy
81,838
+2,395
+3% +$183K 0.48% 56
2015
Q1
$6.2M Buy
79,443
+4,746
+6% +$360K 0.5% 55
2014
Q4
$5.39M Buy
74,697
+1,940
+3% +$135K 0.45% 61
2014
Q3
$4.51M Buy
72,757
+3,725
+5% +$237K 0.41% 69
2014
Q2
$4.4M Buy
69,032
+3,880
+6% +$236K 0.41% 68
2014
Q1
$4.01M Buy
65,152
+475
+0.7% +$27.7K 0.41% 70
2013
Q4
$3.71M Buy
64,677
+2,112
+3% +$120K 0.4% 71
2013
Q3
$3.33M Buy
62,565
+3,695
+6% +$199K 0.4% 78
2013
Q2
$3.03M Buy
+58,870
New +$2.91M 0.37% 77

Other funds holding MDT

KCM Investment Advisors's MDT Position: Q2 2026 in Review

KCM Investment Advisors reduced its Medtronic (MDT) stake by 3.8% in Q2 2026, selling an estimated $44.2K and leaving 14,031 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #213.

KCM Investment Advisors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.4M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • KCM Investment Advisors held 14,031 shares of Medtronic worth $1.1M as of Q2 2026.
  • KCM Investment Advisors sold 548 Medtronic shares in Q2 2026, an estimated $44.2K.
  • Medtronic made up 0.03% of KCM Investment Advisors's portfolio in Q2 2026, its #213 holding.
  • KCM Investment Advisors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • KCM Investment Advisors's Medtronic position peaked at $12.4M in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.